207 results on '"Yang, Chi-Chieh"'
Search Results
2. Real-World Efficacy and Safety of Universal 8-Week Glecaprevir/Pibrentasvir for Treatment-Naïve Patients from a Nationwide HCV Registry in Taiwan
3. An algorithm for simplified hepatitis C virus treatment with non-specialist care based on nation-wide data from Taiwan
4. Enteroscopic Therapy Techniques
5. Effectiveness and safety of 8-week glecaprevir/pibrentasvir in HCV treatment-naïve patients with compensated cirrhosis: real-world experience from Taiwan nationwide HCV registry
6. A new collaborative care approach toward hepatitis C elimination in marginalized populations
7. Metformin reduces hepatocellular carcinoma incidence after successful antiviral therapy in patients with diabetes and chronic hepatitis C in Taiwan
8. Ledipasvir/sofosbuvir for HCV genotype 1, 2, 4–6 infection: Real-world evidence from a nationwide registry in Taiwan
9. Impact of Sofosbuvir-Based Direct-Acting Antivirals on Renal Function in Chronic Hepatitis C Patients With Impaired Renal Function: A Large Cohort Study From the Nationwide HCV Registry Program (TACR)
10. Sofosbuvir/Velpatasvir for Hepatitis C Virus Infection: Real-World Effectiveness and Safety from a Nationwide Registry in Taiwan
11. THU-365 Real-world effectiveness and safety of 8-week glecaprevir/ pibrentasvir for treatment-naïve patients from Taiwan nationwide HCV registry
12. The benefits of hepatitis C viral eradication: a real-world nationwide cohort study in Taiwan
13. Long-term outcome of liver complications in patients with chronic HBV/HCV co-infection after antiviral therapy: a real-world nationwide study on Taiwanese Chronic Hepatitis C Cohort (T-COACH)
14. Metformin and statins reduce hepatocellular carcinoma risk in chronic hepatitis C patients with failed antiviral therapy.
15. Nationwide registry of glecaprevir plus pibrentasvir in the treatment of HCV in Taiwan
16. Artificial intelligence predicts direct-acting antivirals failure among HCV patients: A Nationwide HCV Registry Program
17. Sustained virological response to hepatitis C therapy does not decrease the incidence of systemic lupus erythematosus or rheumatoid arthritis
18. Consolidation period of 18 months no better at promoting off-treatment durability in HBeAg-positive chronic hepatitis B patients with tenofovir disoproxil fumarate treatment than a 12-month period: A prospective randomized cohort study
19. The impact of HCV cure on glycemic indices in patients using glecaprevir/pibrentasvir from nationwide Taiwan HCV registry
20. An algorithm for simplified hepatitis C virus treatment with non-specialist care based on real-world data from a nationwide registry in Taiwan
21. THU-174 - The impact of HCV cure on glycemic indices in patients using glecaprevir/pibrentasvir from nationwide Taiwan HCV registry
22. Risk stratification of hepatocellular carcinoma incidence using a fibrosis-4-based prediction model in patients with chronic hepatitis C receiving antiviral therapy: a nationwide real-world Taiwanese cohort study
23. Toward Hepatitis C Elimination in Marginalized Populations by a Collaborative Multi-setting Approach
24. Effectiveness and safety of 8-week glecaprevir/pibrentasvir in HCV treatment naïve patients with compensated cirrhosis: real-world experience from Taiwan HCV registry
25. Hepatitis C elimination in diabetic population from a shared care cascade cohort- under Changhua-Integrated Program to Stop hepatitis C infection (CHIPS-C)
26. Toward Hepatitis C Elimination in Marginalized Populations by a Collaborative Multi-Setting Approach in Taiwan
27. Elimination of Hepatitis C Virus in a Dialysis Population: A Collaborative Care Model in Taiwan
28. # 2077 Evaluation focal liver lesion with contrast-enhanced ultrasound—A preliminary report
29. # 1645 Efficacy of tenofovir disoproxil fumarate therapy after suboptimal response to entecavir in chronic hepatitis B patient—A community hospitalʼs experience
30. # 1988 Remarkable response of advanced liver hepatocellular carcinoma to sorafenib: A case report
31. # 2160 Hybrid therapy for H. pylori eradication: a retrospective experience from a Taiwan would be medical center
32. For Biliary Dilatation, a Negative Endosonography Needs Additional Image Studies in Weight Loss Suggesting Malignancy
33. Glecaprevir/ Pibrentasvir in the Treatment of Chronic Hepatitis C Patients – A Real-World Nationwide HCV Registry Program (TACR) in Taiwan
34. Double-balloon enteroscopy application in biliary tract disease—its therapeutic and diagnostic functions
35. Association Between Nonalcoholic Fatty Liver Disease and Coronary Artery Calcification
36. Safety and rapid prediction of treatment futility of boceprevir with peginterferon-ribavirin for Asian treatment experienced HCV-1 patients: P-477
37. The Accuracy of Sonography in Predicting Steatosis and Fibrosis in Chronic Hepatitis C
38. Hepatitis C virus eradication decreases the risks of liver cirrhosis and cirrhosis‐related complications (Taiwanese chronic hepatitis C cohort)
39. Factors associated with treatment failure of direct‐acting antivirals for chronic hepatitis C: A real‐world nationwide hepatitis C virus registry programme in Taiwan
40. THU-217 - An algorithm for simplified hepatitis C virus treatment with non-specialist care based on real-world data from a nationwide registry in Taiwan
41. Lactobacillus Attenuate the Progression of Pancreatic Cancer Promoted by Porphyromonas Gingivalis in K-rasG12D Transgenic Mice
42. Successful Antiviral Therapy Reduces Risk of Schizophrenia Among Chronic Hepatitis C Patients: A Nationwide Real-World Taiwanese Cohort (T-COACH)
43. Hepatitis C elimination in hemodialysis population of a county - an innovative collaborative care model in Taiwan
44. Endoscopic submucosal dissection for superficial pharyngeal squamous cell carcinoma
45. Extrahepatic Malignancy Among Patients With Chronic Hepatitis C After Antiviral Therapy: A Real-World Nationwide Study on Taiwanese Chronic Hepatitis C Cohort (T-COACH)
46. Tenofovir disoproxil fumarate for patients with chronic hepatitis B who suboptimal response to non‐tenofovir disoproxil fumarate nucleos(t)ide analogs therapy
47. Reappraisal of Endosonography of Ampullary Tumors: Correlation with Transabdominal Sonography, CT, and MRI
48. Relationship between matrix metalloproteinase-2 activity and cystatin C levels in patients with hepatic disease
49. Prevalence and etiology of elevated serum alanine aminotransferase level in an adult population in Taiwan
50. Gastric Glomus Tumor: A Hypervascular Submucosal Tumor on Power Doppler Endosonography
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.